Global Flunarizine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Flunarizine market size was valued at US$ 285 million in 2024 and is forecast to a readjusted size of USD 359 million by 2031 with a CAGR of 3.4% during review period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report is a detailed and comprehensive analysis for global Flunarizine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Flunarizine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Flunarizine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Flunarizine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, Cipla Limited, Torrent Pharmaceuticals, Aa Pharma, Karnataka Antibiotics and Pharmaceuticals, Cadila Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Fdc, Alkem Laboratories, Intas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Flunarizine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablets
Capsules
Market segment by Application
Hospital
Clinic
Clinical Institution
Academic Research
Others
Major players covered
Johnson and Johnson
Cipla Limited
Torrent Pharmaceuticals
Aa Pharma
Karnataka Antibiotics and Pharmaceuticals
Cadila Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
Fdc
Alkem Laboratories
Intas Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flunarizine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flunarizine, with price, sales quantity, revenue, and global market share of Flunarizine from 2020 to 2025.
Chapter 3, the Flunarizine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flunarizine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Flunarizine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flunarizine.
Chapter 14 and 15, to describe Flunarizine sales channel, distributors, customers, research findings and conclusion.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report is a detailed and comprehensive analysis for global Flunarizine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Flunarizine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Flunarizine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Flunarizine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Flunarizine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson, Cipla Limited, Torrent Pharmaceuticals, Aa Pharma, Karnataka Antibiotics and Pharmaceuticals, Cadila Pharmaceuticals, Orchid Chemicals and Pharmaceuticals, Fdc, Alkem Laboratories, Intas Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Flunarizine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablets
Capsules
Market segment by Application
Hospital
Clinic
Clinical Institution
Academic Research
Others
Major players covered
Johnson and Johnson
Cipla Limited
Torrent Pharmaceuticals
Aa Pharma
Karnataka Antibiotics and Pharmaceuticals
Cadila Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
Fdc
Alkem Laboratories
Intas Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flunarizine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flunarizine, with price, sales quantity, revenue, and global market share of Flunarizine from 2020 to 2025.
Chapter 3, the Flunarizine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flunarizine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Flunarizine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flunarizine.
Chapter 14 and 15, to describe Flunarizine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
88 Pages
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Flunarizine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Tablets
- 1.3.3 Capsules
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Flunarizine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Clinical Institution
- 1.4.5 Academic Research
- 1.4.6 Others
- 1.5 Global Flunarizine Market Size & Forecast
- 1.5.1 Global Flunarizine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Flunarizine Sales Quantity (2020-2031)
- 1.5.3 Global Flunarizine Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Johnson and Johnson
- 2.1.1 Johnson and Johnson Details
- 2.1.2 Johnson and Johnson Major Business
- 2.1.3 Johnson and Johnson Flunarizine Product and Services
- 2.1.4 Johnson and Johnson Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Johnson and Johnson Recent Developments/Updates
- 2.2 Cipla Limited
- 2.2.1 Cipla Limited Details
- 2.2.2 Cipla Limited Major Business
- 2.2.3 Cipla Limited Flunarizine Product and Services
- 2.2.4 Cipla Limited Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Cipla Limited Recent Developments/Updates
- 2.3 Torrent Pharmaceuticals
- 2.3.1 Torrent Pharmaceuticals Details
- 2.3.2 Torrent Pharmaceuticals Major Business
- 2.3.3 Torrent Pharmaceuticals Flunarizine Product and Services
- 2.3.4 Torrent Pharmaceuticals Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Torrent Pharmaceuticals Recent Developments/Updates
- 2.4 Aa Pharma
- 2.4.1 Aa Pharma Details
- 2.4.2 Aa Pharma Major Business
- 2.4.3 Aa Pharma Flunarizine Product and Services
- 2.4.4 Aa Pharma Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Aa Pharma Recent Developments/Updates
- 2.5 Karnataka Antibiotics and Pharmaceuticals
- 2.5.1 Karnataka Antibiotics and Pharmaceuticals Details
- 2.5.2 Karnataka Antibiotics and Pharmaceuticals Major Business
- 2.5.3 Karnataka Antibiotics and Pharmaceuticals Flunarizine Product and Services
- 2.5.4 Karnataka Antibiotics and Pharmaceuticals Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Karnataka Antibiotics and Pharmaceuticals Recent Developments/Updates
- 2.6 Cadila Pharmaceuticals
- 2.6.1 Cadila Pharmaceuticals Details
- 2.6.2 Cadila Pharmaceuticals Major Business
- 2.6.3 Cadila Pharmaceuticals Flunarizine Product and Services
- 2.6.4 Cadila Pharmaceuticals Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Cadila Pharmaceuticals Recent Developments/Updates
- 2.7 Orchid Chemicals and Pharmaceuticals
- 2.7.1 Orchid Chemicals and Pharmaceuticals Details
- 2.7.2 Orchid Chemicals and Pharmaceuticals Major Business
- 2.7.3 Orchid Chemicals and Pharmaceuticals Flunarizine Product and Services
- 2.7.4 Orchid Chemicals and Pharmaceuticals Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Orchid Chemicals and Pharmaceuticals Recent Developments/Updates
- 2.8 Fdc
- 2.8.1 Fdc Details
- 2.8.2 Fdc Major Business
- 2.8.3 Fdc Flunarizine Product and Services
- 2.8.4 Fdc Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Fdc Recent Developments/Updates
- 2.9 Alkem Laboratories
- 2.9.1 Alkem Laboratories Details
- 2.9.2 Alkem Laboratories Major Business
- 2.9.3 Alkem Laboratories Flunarizine Product and Services
- 2.9.4 Alkem Laboratories Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Alkem Laboratories Recent Developments/Updates
- 2.10 Intas Pharmaceuticals
- 2.10.1 Intas Pharmaceuticals Details
- 2.10.2 Intas Pharmaceuticals Major Business
- 2.10.3 Intas Pharmaceuticals Flunarizine Product and Services
- 2.10.4 Intas Pharmaceuticals Flunarizine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Intas Pharmaceuticals Recent Developments/Updates
- 3 Competitive Environment: Flunarizine by Manufacturer
- 3.1 Global Flunarizine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Flunarizine Revenue by Manufacturer (2020-2025)
- 3.3 Global Flunarizine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Flunarizine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Flunarizine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Flunarizine Manufacturer Market Share in 2024
- 3.5 Flunarizine Market: Overall Company Footprint Analysis
- 3.5.1 Flunarizine Market: Region Footprint
- 3.5.2 Flunarizine Market: Company Product Type Footprint
- 3.5.3 Flunarizine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Flunarizine Market Size by Region
- 4.1.1 Global Flunarizine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Flunarizine Consumption Value by Region (2020-2031)
- 4.1.3 Global Flunarizine Average Price by Region (2020-2031)
- 4.2 North America Flunarizine Consumption Value (2020-2031)
- 4.3 Europe Flunarizine Consumption Value (2020-2031)
- 4.4 Asia-Pacific Flunarizine Consumption Value (2020-2031)
- 4.5 South America Flunarizine Consumption Value (2020-2031)
- 4.6 Middle East & Africa Flunarizine Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Flunarizine Sales Quantity by Type (2020-2031)
- 5.2 Global Flunarizine Consumption Value by Type (2020-2031)
- 5.3 Global Flunarizine Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Flunarizine Sales Quantity by Application (2020-2031)
- 6.2 Global Flunarizine Consumption Value by Application (2020-2031)
- 6.3 Global Flunarizine Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Flunarizine Sales Quantity by Type (2020-2031)
- 7.2 North America Flunarizine Sales Quantity by Application (2020-2031)
- 7.3 North America Flunarizine Market Size by Country
- 7.3.1 North America Flunarizine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Flunarizine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Flunarizine Sales Quantity by Type (2020-2031)
- 8.2 Europe Flunarizine Sales Quantity by Application (2020-2031)
- 8.3 Europe Flunarizine Market Size by Country
- 8.3.1 Europe Flunarizine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Flunarizine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Flunarizine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Flunarizine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Flunarizine Market Size by Region
- 9.3.1 Asia-Pacific Flunarizine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Flunarizine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Flunarizine Sales Quantity by Type (2020-2031)
- 10.2 South America Flunarizine Sales Quantity by Application (2020-2031)
- 10.3 South America Flunarizine Market Size by Country
- 10.3.1 South America Flunarizine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Flunarizine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Flunarizine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Flunarizine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Flunarizine Market Size by Country
- 11.3.1 Middle East & Africa Flunarizine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Flunarizine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Flunarizine Market Drivers
- 12.2 Flunarizine Market Restraints
- 12.3 Flunarizine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Flunarizine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Flunarizine
- 13.3 Flunarizine Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Flunarizine Typical Distributors
- 14.3 Flunarizine Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
